83,022 Shares in Corteva, Inc. $CTVA Bought by Cibc World Market Inc.

Cibc World Market Inc. purchased a new stake in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 83,022 shares of the company’s stock, valued at approximately $7,031,000.

A number of other institutional investors also recently modified their holdings of CTVA. OMERS ADMINISTRATION Corp acquired a new position in shares of Corteva during the second quarter worth about $6,350,000. Osmosis Investment Management UK Ltd acquired a new stake in Corteva in the 2nd quarter valued at approximately $549,000. Sanctuary Advisors LLC acquired a new stake in Corteva in the 2nd quarter valued at approximately $7,087,000. Meiji Yasuda Asset Management Co Ltd. bought a new stake in Corteva in the 2nd quarter valued at approximately $905,000. Finally, Haverford Trust Co acquired a new position in Corteva during the 2nd quarter worth approximately $5,522,000. 81.54% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on CTVA. Mizuho raised their price target on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. JPMorgan Chase & Co. boosted their price objective on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. BMO Capital Markets increased their target price on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. Barclays lifted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Finally, Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Stock Up 0.4%

NYSE:CTVA opened at $83.18 on Wednesday. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The firm has a market capitalization of $55.50 billion, a price-to-earnings ratio of 55.09, a price-to-earnings-growth ratio of 2.54 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock’s 50 day moving average price is $82.39 and its two-hundred day moving average price is $80.37.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the prior year, the firm posted $2.20 EPS. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.